Regeneron Pharmaceuticals, Inc., announced FDA approval of evinacumab-dgnb (Evkeeza) for children as young as 1 year of age with homozygous familial hypercholesterolemia (HoFH), expanding treatment ...
Interesting Engineering on MSN
Can Optimus make America win the humanoid robot race? Here’s the verdict
After four years of hype, Optimus shows some progress, yet the humanoid struggles to prove it's worth beyond staged demos.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback